1. Home
  2. NOTV vs ELVA Comparison

NOTV vs ELVA Comparison

Compare NOTV & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • ELVA
  • Stock Information
  • Founded
  • NOTV 1974
  • ELVA 1996
  • Country
  • NOTV United States
  • ELVA Canada
  • Employees
  • NOTV N/A
  • ELVA N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • ELVA
  • Sector
  • NOTV Health Care
  • ELVA
  • Exchange
  • NOTV Nasdaq
  • ELVA Nasdaq
  • Market Cap
  • NOTV 137.5M
  • ELVA 125.5M
  • IPO Year
  • NOTV 1997
  • ELVA N/A
  • Fundamental
  • Price
  • NOTV $2.05
  • ELVA $3.31
  • Analyst Decision
  • NOTV Strong Buy
  • ELVA Strong Buy
  • Analyst Count
  • NOTV 1
  • ELVA 5
  • Target Price
  • NOTV $5.00
  • ELVA $6.10
  • AVG Volume (30 Days)
  • NOTV 888.5K
  • ELVA 87.4K
  • Earning Date
  • NOTV 08-07-2025
  • ELVA 08-12-2025
  • Dividend Yield
  • NOTV N/A
  • ELVA N/A
  • EPS Growth
  • NOTV N/A
  • ELVA N/A
  • EPS
  • NOTV N/A
  • ELVA N/A
  • Revenue
  • NOTV $480,402,000.00
  • ELVA $48,016,000.00
  • Revenue This Year
  • NOTV $4.99
  • ELVA $55.29
  • Revenue Next Year
  • NOTV $5.39
  • ELVA $63.69
  • P/E Ratio
  • NOTV N/A
  • ELVA N/A
  • Revenue Growth
  • NOTV N/A
  • ELVA N/A
  • 52 Week Low
  • NOTV $1.15
  • ELVA $1.67
  • 52 Week High
  • NOTV $6.48
  • ELVA $3.71
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 42.15
  • ELVA 54.18
  • Support Level
  • NOTV $2.64
  • ELVA $3.30
  • Resistance Level
  • NOTV $3.19
  • ELVA $3.47
  • Average True Range (ATR)
  • NOTV 0.33
  • ELVA 0.17
  • MACD
  • NOTV -0.09
  • ELVA -0.03
  • Stochastic Oscillator
  • NOTV 5.93
  • ELVA 45.21

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About ELVA Electrovaya Inc.

Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.

Share on Social Networks: